Doctor profile · Federal record
Dr. Inaganti Shah, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Omaha, NE
- NPI 1295829042
- Accepts Medicare
- 38 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6901 N 72Nd St, Suite 2244
Omaha, NE 681221709
(402) 572-3535
fax (402) 572-2688 - Mailing address
-
Po Box 641850
Omaha, NE 681647850
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 10, 2013
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Nebraska #21140 · Iowa #33127
- Medicaid (2)
- IA #0538751 · NE #47077065413
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295829042. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
200,007
Distinct HCPCS
10
Medicare allowed
$2,541,936
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 46,440 | 66 | $3 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 41,250 | 42 | $1 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 18,000 | 18 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 16,460 | 26 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 13,200 | 25 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 12,600 | 61 | $23 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,900 | 19 | $48 | |
J9267 |
Injection, paclitaxel, 1 mg | 7,140 | 19 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 5,500 | 12 | $0 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 4,020 | 23 | $29 |
In context: peer comparison
Among 16 peers in Omaha Hematology & Oncology Physician, average services per provider: 2,091. This provider delivers 96× the peer median.Open Payments
Industry payments received
All-time total
$205
Transactions
9
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 3 | $56.32 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $49.66 | |
| Merck Sharp & Dohme LLC | 1 | $40.50 | |
| Octapharma USA, INC. | 1 | $25.44 | |
| Bayer Healthcare Pharmaceuticals INC. | 1 | $17.98 | |
| Aveo Pharmaceuticals, INC. | 1 | $15.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
587
Patients
139
Total drug cost
$572,119
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 103 | 37 | $1,375 |
| Anastrozole | Generic | 97 | 23 | $1,687 |
| Prednisone | Generic | 61 | 14 | $375 |
| Abiraterone Acetate | Generic | 55 | 0 | $133,355 |
| Ondansetron Hcl | Generic | 42 | 26 | $416 |
| Hydroxyurea | Generic | 39 | 12 | $1,281 |
| Xarelto (Rivaroxaban) | Brand | 29 | 0 | $20,380 |
| Imbruvica (Ibrutinib) | Brand | 24 | 0 | $410,849 |
| Acyclovir | Generic | 22 | 0 | $220 |
| Tamoxifen Citrate | Generic | 22 | 0 | $604 |
Hospital affiliations
Frequently asked questions
What is Dr. Inaganti Shah's medical specialty?
Dr. Inaganti Shah practices Hematology & Oncology Physician in Omaha, NE.
Where does Dr. Inaganti Shah practice?
Dr. Inaganti Shah practices at 6901 N 72Nd St, Omaha, NE 681221709. Office phone: 4025723535.
What is Dr. Inaganti Shah's NPI?
Dr. Inaganti Shah's National Provider Identifier (NPI) is 1295829042, issued by NPPES.
Does Dr. Inaganti Shah accept Medicare assignment?
Yes. Dr. Inaganti Shah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Inaganti Shah commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101). Source: CMS Medicare Physician & Other Practitioners file.